Skip to main content

BlueCrest Capital Management Ltd

Position in PVLA — Palvella Therapeutics, Inc.

CIK 1610880 ST HELIER, Y9

Position in PVLA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,493,000
New position
Shares Held
20,000
first reported quarter
Ownership
0.139%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 0% Shared 100% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BlueCrest Capital Management Ltd holds $3,702,055 across 3 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in PVLA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $2,493,000 20,000